1 result for "RVL Pharmaceuticals, Inc."
Add this URL to any RSS reader. Updated daily.
Oxymetazoline Therapeutic Compositions Stabilized for Long-Term Storage
USPTO granted patent US12605363B2 to RVL Pharmaceuticals, Inc. covering compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long-term storage. The patent includes 20 claims and names Tina deVries and David Jacobs as inventors, with a filing date of December 23, 2022.
Routine
Rule
Intellectual Property
Get alerts for "RVL Pharmaceuticals, Inc."
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Browse Categories
Agriculture & Food Safety
73
AI Regulation
3
Banking & Finance
414
Consumer Protection
89
Courts & Legal
411
Data Privacy & Cybersecurity
90
Defense & National Security
53
Education
55
Energy
100
Environment
152
Gaming
2
Government & Legislation
431
Healthcare
15
Healthcare & Life Sciences
375
Immigration
10
Insurance
76
Labor & Employment
138
Pharma & Drug Safety
21
Professional Licensing
8
Real Estate & Housing
78
Securities & Markets
154
Tax
78
Telecom & Technology
47
Trade & Sanctions
141
Transportation
91
Get alerts for "RVL Pharmaceuticals, Inc."
We'll email you when new changes match "RVL Pharmaceuticals, Inc.".
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.
You're subscribed!